Metformin Fails to Improve Insulin Resistance in Type 1 Diabetes

Metformin failed to present improvements in liver, muscle, or adipose tissue insulin resistance after treatment for 26 weeks in patients with type 1 diabetes (T1D), based on data from the Insulin in Type 1 Diabetes Managed with Metformin…

Continue Reading